Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients

M. Barbir; S. Kushwaha; B. Hunt; A. Macken; M. Yacoub; G. Thompson; D. Robinson; Andrew Mitchell

doi:10.1016/0140-6736(92)92756-6

Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients

M. Barbir, S. Kushwaha, B. Hunt, A. Macken, M. Yacoub, G. Thompson, D. Robinson, Andrew Mitchell

Cardiovascular Medicine

Research output: Contribution to journal › Article › peer-review

77 Scopus citations

Abstract

High concentrations of serum lipoprotein(a) (Lp(a)) are associated with an increased risk of atherosclerotic vascular disease in the non-transplanted population. However its relation with accelerated coronary artery disease (CAD) in cardiac transplant recipients has not been reported. We measured serum Lp(a) in 130 cardiac transplant recipients undergoing routine follow-up, which included annual coronary angiography. The median Lp(a) concentration in 33 patients with CAD was 71 mg/dl, which was significantly higher than the corresponding value of 22 mg/dL in the 97 patients without CAD (p= 0·0006). Multivariant analysis showed the serum Lp(a) value to be a higher significant risk factor for CAD irrespective of the other factors included in the regression analysis. Thus a high concentration of serum Lp(a) is an important, independent risk factor for the development of accelerated CAD in transplant recipients.

Original language	English (US)
Pages (from-to)	1500-1502
Number of pages	3
Journal	The Lancet
Volume	340
Issue number	8834-8835
DOIs	https://doi.org/10.1016/0140-6736(92)92756-6
State	Published - Dec 26 1992

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/0140-6736(92)92756-6

Cite this

@article{6c3662087f61407499b2a84c65c2a9c2,

title = "Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients",

abstract = "High concentrations of serum lipoprotein(a) (Lp(a)) are associated with an increased risk of atherosclerotic vascular disease in the non-transplanted population. However its relation with accelerated coronary artery disease (CAD) in cardiac transplant recipients has not been reported. We measured serum Lp(a) in 130 cardiac transplant recipients undergoing routine follow-up, which included annual coronary angiography. The median Lp(a) concentration in 33 patients with CAD was 71 mg/dl, which was significantly higher than the corresponding value of 22 mg/dL in the 97 patients without CAD (p= 0·0006). Multivariant analysis showed the serum Lp(a) value to be a higher significant risk factor for CAD irrespective of the other factors included in the regression analysis. Thus a high concentration of serum Lp(a) is an important, independent risk factor for the development of accelerated CAD in transplant recipients.",

author = "M. Barbir and S. Kushwaha and B. Hunt and A. Macken and M. Yacoub and G. Thompson and D. Robinson and Andrew Mitchell",

year = "1992",

month = dec,

day = "26",

doi = "10.1016/0140-6736(92)92756-6",

language = "English (US)",

volume = "340",

pages = "1500--1502",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "8834-8835",

}

TY - JOUR

T1 - Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients

AU - Barbir, M.

AU - Kushwaha, S.

AU - Hunt, B.

AU - Macken, A.

AU - Yacoub, M.

AU - Thompson, G.

AU - Robinson, D.

AU - Mitchell, Andrew

PY - 1992/12/26

Y1 - 1992/12/26

N2 - High concentrations of serum lipoprotein(a) (Lp(a)) are associated with an increased risk of atherosclerotic vascular disease in the non-transplanted population. However its relation with accelerated coronary artery disease (CAD) in cardiac transplant recipients has not been reported. We measured serum Lp(a) in 130 cardiac transplant recipients undergoing routine follow-up, which included annual coronary angiography. The median Lp(a) concentration in 33 patients with CAD was 71 mg/dl, which was significantly higher than the corresponding value of 22 mg/dL in the 97 patients without CAD (p= 0·0006). Multivariant analysis showed the serum Lp(a) value to be a higher significant risk factor for CAD irrespective of the other factors included in the regression analysis. Thus a high concentration of serum Lp(a) is an important, independent risk factor for the development of accelerated CAD in transplant recipients.

AB - High concentrations of serum lipoprotein(a) (Lp(a)) are associated with an increased risk of atherosclerotic vascular disease in the non-transplanted population. However its relation with accelerated coronary artery disease (CAD) in cardiac transplant recipients has not been reported. We measured serum Lp(a) in 130 cardiac transplant recipients undergoing routine follow-up, which included annual coronary angiography. The median Lp(a) concentration in 33 patients with CAD was 71 mg/dl, which was significantly higher than the corresponding value of 22 mg/dL in the 97 patients without CAD (p= 0·0006). Multivariant analysis showed the serum Lp(a) value to be a higher significant risk factor for CAD irrespective of the other factors included in the regression analysis. Thus a high concentration of serum Lp(a) is an important, independent risk factor for the development of accelerated CAD in transplant recipients.

UR - http://www.scopus.com/inward/record.url?scp=0026496003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026496003&partnerID=8YFLogxK

U2 - 10.1016/0140-6736(92)92756-6

DO - 10.1016/0140-6736(92)92756-6

M3 - Article

C2 - 1361597

AN - SCOPUS:0026496003

SN - 0140-6736

VL - 340

SP - 1500

EP - 1502

JO - The Lancet

JF - The Lancet

IS - 8834-8835

ER -

Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this